The care of patients with venous thrombosis and its complications, with an emphasis on tailoring treatments to an individual's level of risk, and on evaluations for inherited and acquired hypercoagulable syndromes when appropriate. Evaluation and management of patients with premature or unexplained arterial vascular disease and the role of novel risk factors in their management. Evaluation and management of antiphospholipid syndrome. Optimization of the quality of acute and chronic administration of anticoagulant medications for treatment and prevention of thrombosis.
1996: M.Sc., Epidemiology, Harvard University, School of Public Health, Boston, Massachusetts
1989: M.D., University of Vermont College of Medicine, Burlington, Vermont
1985: B.S. (cum laude), Biology, University of Vermont, Burlington, Vermont
1992-1995 Fellow in Hematology, Department of Medicine, University of Vermont and Fletcher Allen Health Care, Burlington, Vermont
1993-1995 Research Fellow in Hemostasis, Department of Pathology, University of Vermont, Burlington, Vermont
1989-1992 Resident in Internal Medicine, Traditional Track, Department of Medicine, Medical Center Hospital of Vermont, Burlington, Vermont
The epidemiology of coagulation, inflammation, and other vascular-related domains in relation to etiology and pathogenesis of cardiovascular diseases (myocardial infarction, stroke, and venous thrombosis) and other diseases of aging. The role of disorders of coagulation in venous and arterial thrombotic disease, and the therapy of these disorders. Racial disparities, especially in stroke and venous disease. Etiologic factors in post-thrombotic syndrome and chronic venous disease.
Cushman M, McClure L, Howard G, Howard, VJ, Jenny NS. Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem 2009;55:1627-36.
Cushman M, O’Meara ES, Folsom AR, Heckbert SR. Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood 2009;114:2878-83Cushman M, Callas PW, Denenberg JO, Bovill EG, Criqui MH. Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study. J Thromb Haemost 2010;8:1730-5.
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis and chronic thromboembolic pulmonary hypertension. A Scientific Statement from the American Heart Association. Circulation 2011;123.Howard G, Cushman M, Kissela BM, Kleindorfer DO, McClure LA, Safford MM, Rhodes JD, Soliman EZ, Moy CS, Judd SE, Howard VJ. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half full (empty?) glass. In press, Stroke.
For a complete list of Mary Cushman's publications, please visit Google Scholar